Decline in Residual Renal Function in Automated Compared with Continuous Ambulatory Peritoneal Dialysis
Authors:
- Wieneke Marleen MichelsWMWieneke Marleen Michels
- Marion VerduijnMVMarion Verduijn
- Diana C. GrootendorstDGDiana C. Grootendorst
- Saskia le CessieSCSaskia le Cessie
- Elisabeth Wilhelmina BoeschotenEBElisabeth Wilhelmina Boeschoten
- Friedo Wilhelm DekkerFDFriedo Wilhelm Dekker
- Raymond Theodorus KredietRKRaymond Theodorus Krediet
Open Access
- 1 March 2011
- journal article
- research article
- Published by Wolters Kluwer Health in Clinical Journal of the American Society of Nephrology
- Vol. 6 (3) , 537-542
Abstract
Summary: Background and objectives: We compared the decline of RRF in patients starting dialysis on APD with those starting on CAPD, because a faster decline on APD has been suggested. Design, setting, participants, & measurements: NECOSAD patients starting dialysis on APD or CAPD with RRF at baseline were included and followed for 3 years. Residual GFR (rGFR) was the mean of urea and creatinine clearances. Differences in yearly decline of rGFR were estimated in analyses with linear repeated measures models, whereas the risk of complete loss of RRF was estimated by calculating hazard ratios (HRs) for APD compared with CAPD. As-treated (AT) and intention-to-treat (ITT) designs were used. All of the analyses were adjusted for age, gender, comorbidity, and primary kidney disease and stratified according to follow-up and mean baseline GFR. Results: The 505 CAPD and 78 APD patients had no major baseline differences. No differences were found in the analyses on yearly decline of rGFR. APD patients did have a higher risk of losing RRF in the first year (ITT crude HR 2.43 [confidence interval 95%, 1.48 to 4.00], adjusted 2.66 [1.60 to 4.44]; AT crude 1.89 [1.04 to 3.45], adjusted 2.15 [1.16 to 3.98]). The higher risk of losing all RRF was most pronounced in patients with the highest rGFR at baseline (ITT; crude 3.91 [1.54 to 9.94], adjusted 1.85 to 14.17). Conclusions: The risk of losing RRF is higher for patients starting dialysis on APD compared with those starting on CAPD, especially in the first year.Keywords
This publication has 39 references indexed in Scilit:
- Treatment with Angiotensin II Inhibitors and Residual Renal Function in Peritoneal Dialysis PatientsPeritoneal Dialysis International: Journal of the International Society for Peritoneal Dialysis, 2011
- Longitudinal relationships between fluid status, inflammation, urine volume and plasma metabolites of icodextrin in patients randomized to glucose or icodextrin for the long exchangeNephrology Dialysis Transplantation, 2008
- Randomized controlled study of biocompatible peritoneal dialysis solutions: Effect on residual renal functionKidney International, 2008
- A decline in residual glomerular filtration during the use of icodextrin may be due to underhydrationKidney International, 2005
- Compared time profiles of ultrafiltration, sodium removal, and renal function in incident CAPD and automated peritoneal dialysis patientsAmerican Journal of Kidney Diseases, 2004
- Effect of starting with hemodialysis compared with peritoneal dialysis in patients new on dialysis treatment: A randomized controlled trialKidney International, 2003
- Effect of icodextrin on volume status, blood pressure and echocardiographic parameters: A randomized studyKidney International, 2003
- Predictors of the rate of decline of residual renal function in incident dialysis patientsKidney International, 2002
- Predictors of poor outcome in chronic dialysis patients: The Netherlands cooperative study on the adequacy of dialysisAmerican Journal of Kidney Diseases, 2000
- Comorbidity, urea kinetics, and appetite in continuous ambulatory peritoneal dialysis patients: Their interrelationship and prediction of survivalAmerican Journal of Kidney Diseases, 1995